{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:15:27Z","timestamp":1791850527397,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1085-z","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T20:05:02Z","timestamp":1533153902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Comparison of definite chemoradiation therapy with carboplatin\/paclitaxel or cisplatin\/5-fluoruracil in patients with squamous cell carcinoma of the esophagus"],"prefix":"10.1186","volume":"13","author":[{"given":"Stefan","family":"M\u00fcnch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi U.","family":"Pigorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Deve\u010dka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Dapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Friess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickmer","family":"Braren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"1085_CR1","unstructured":"Howlader N N.A. Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, based on November 2016 SEER data submission, posted to the SEER web site,Bethesda, MD, National Cancer Institute 2017\n                    https:\/\/seer.cancer.gov\/csr\/1975_2014\/\n                    \n                  \n                           ."},{"key":"1085_CR2","volume-title":"GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase no. 11","author":"JSI Ferlay","year":"2013","unstructured":"Ferlay JSI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase no. 11. International Agency for Research on Cancer: Lyon; 2013. Available from: \n                    http:\/\/globocan.iarc.fr\n                    \n                  ."},{"issue":"6","key":"1085_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5732\/cjc.011.10390","volume":"31","author":"HZ Zhang","year":"2012","unstructured":"Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and western populations. Chin J Cancer. 2012;31(6):281\u20136.","journal-title":"Chin J Cancer"},{"issue":"11","key":"1085_CR4","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1055\/s-0041-107381","volume":"53","author":"R Porschen","year":"2015","unstructured":"Porschen R, et al. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des \u00d6sophagus (Langversion 1.0 - September 2015, AWMF-Registernummer: 021\/023OL). Z Gastroenterol. 2015;53(11):1288\u2013347. Z Gastroenterol, 2015 53(11): p. 1288\u2013347","journal-title":"Z Gastroenterol"},{"issue":"22","key":"1085_CR5","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384.","journal-title":"N Engl J Med"},{"issue":"7","key":"1085_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","volume":"26","author":"J Tepper","year":"2008","unstructured":"Tepper J, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086\u201392.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1085_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/bjs.7455","volume":"98","author":"M Kranzfelder","year":"2011","unstructured":"Kranzfelder M, et al. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg. 2011;98(6):768\u201383.","journal-title":"Br J Surg"},{"key":"1085_CR8","unstructured":"National Comprehensive Cancer Network Clinical practise guidelines in oncology - esophageal and esophagogastric junction cancers. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/esophageal.pdf\n                    \n                  . (2018), Accessed 02 June 2018."},{"issue":"4","key":"1085_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/dote.12110","volume":"27","author":"RL Blom","year":"2014","unstructured":"Blom RL, et al. Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma. Dis Esophagus. 2014;27(4):380\u20137.","journal-title":"Dis Esophagus"},{"issue":"1","key":"1085_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13014-017-0904-y","volume":"12","author":"S Munch","year":"2017","unstructured":"Munch S, et al. Comparison of neoadjuvant chemoradiation with carboplatin\/ paclitaxel or cisplatin\/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat Oncol. 2017;12(1):182.","journal-title":"Radiat Oncol"},{"issue":"4","key":"1085_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/COC.0b013e3181aaca26","volume":"33","author":"BN Ruppert","year":"2010","unstructured":"Ruppert BN, et al. Cisplatin\/Irinotecan versus carboplatin\/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer. Am J Clin Oncol. 2010;33(4):346\u201352.","journal-title":"Am J Clin Oncol"},{"key":"1085_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2407-14-56","volume":"14","author":"N Haj Mohammad","year":"2014","unstructured":"Haj Mohammad N, et al. Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma. BMC Cancer. 2014;14:56.","journal-title":"BMC Cancer"},{"issue":"4","key":"1085_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3727\/096504016X14537290676865","volume":"23","author":"V Noronha","year":"2016","unstructured":"Noronha V, et al. Clinical outcome in definitive concurrent Chemoradiation with weekly paclitaxel and carboplatin for locally advanced esophageal and Junctional Cancer. Oncol Res. 2016;23(4):183\u201395.","journal-title":"Oncol Res"},{"issue":"3","key":"1085_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/annonc\/mdt589","volume":"25","author":"J Honing","year":"2014","unstructured":"Honing J, et al. A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients. Ann Oncol. 2014;25(3):638\u201343.","journal-title":"Ann Oncol"},{"issue":"24","key":"1085_CR15","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","volume":"326","author":"A Herskovic","year":"1992","unstructured":"Herskovic A, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593\u20138.","journal-title":"N Engl J Med"},{"issue":"17","key":"1085_CR16","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01) Radiation Therapy Oncology Group. JAMA. 1999;281(17):1623\u20137.","journal-title":"JAMA"},{"issue":"5","key":"1085_CR17","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","volume":"20","author":"BD Minsky","year":"2002","unstructured":"Minsky BD, et al. INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167\u201374.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1085_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4143\/crt.2016.354","volume":"49","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, et al. Dose-response relationship between radiation dose and loco-regional control in patients with stage II-III esophageal Cancer treated with definitive Chemoradiotherapy. Cancer Res Treat. 2017;49(3):669\u201377.","journal-title":"Cancer Res Treat"},{"issue":"10","key":"1085_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00066-016-1020-x","volume":"192","author":"S Munch","year":"2016","unstructured":"Munch S, et al. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT. Strahlenther Onkol. 2016;192(10):722\u20139.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1085_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13014-017-0863-3","volume":"12","author":"MF Haefner","year":"2017","unstructured":"Haefner MF, et al. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity. Radiat Oncol. 2017;12(1):131.","journal-title":"Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1085-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:16:56Z","timestamp":1564687016000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1085-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1085-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"28 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the ethics standards at the Technical University of Munich (TUM) (ethical vote N\u00b0 31\/18S).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"139"}}